Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stathmin-3 is a microtubule-destabilizing phosphoprotein encoded by the STMN3 gene, primarily expressed in neuronal tissues. As a member of the stathmin/oncoprotein 18 family, it regulates microtubule dynamics, impacting processes such as neuron projection development and neuronal plasticity. It forms complexes with tubulin, disrupting microtubule formation and facilitating cellular events crucial for neural differentiation and signaling. Stathmin-3's microtubule-destabilizing activity is antagonized by the transcription factor STAT3. While it shares functional similarity with other stathmin family members, its role as a therapeutic target or biomarker is currently unestablished.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stathmin-3 (STMN3).